XML 46 R37.htm IDEA: XBRL DOCUMENT
v3.10.0.1

DEBT (Details Narrative) |  |  |  |  |  | 1 Months Ended | 6 Months Ended | 12 Months Ended |  |  |  |  |  |  |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
May 12, 2017 USD ($) | May 05, 2017 USD ($) | Apr. 10, 2017 USD ($) | Mar. 16, 2017 USD ($) | Aug. 04, 2016 USD ($) shares | May 31, 2018 USD ($) | Mar. 16, 2018 USD ($) | Feb. 19, 2018 USD ($) | Jan. 18, 2018 USD ($) | May 16, 2017 USD ($) | Mar. 23, 2017 USD ($) shares | Mar. 20, 2017 USD ($) | Nov. 16, 2015 USD ($) | Jun. 30, 2018 USD ($) shares | Jun. 30, 2018 CAD ($) shares | Dec. 31, 2017 USD ($) | Apr. 02, 2018 USD ($) | Mar. 31, 2018 USD ($) | Nov. 16, 2017 USD ($) | Jul. 31, 2017 USD ($) | Jun. 30, 2017 USD ($) | Jan. 31, 2017 USD ($) | Dec. 31, 2016 USD ($) | Nov. 30, 2016 USD ($) | Oct. 31, 2016 USD ($) | Sep. 30, 2016 USD ($) | Sep. 13, 2016 USD ($)
Debt outstanding amount |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 3,078,442 |  |  |  |  |  |  |  |  |  |  |  |  |
Accrued interest |  |  |  |  |  |  |  |  |  |  |  |  |  | 269,930 |  |  |  |  |  |  |  |  |  |  |  |  |
Debt discount |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,216,000 |  | $ 3,350,000 |  |  |  |  |  |  |  |  |  |  |
Amortization of debt discount |  |  |  |  |  |  |  | $ 392,272 |  |  |  |  |  | 1,668,926 |  | 360,890 |  |  |  |  |  |  |  |  |  |  |
Cash received |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 40,858 |  |  |  |  |  |  |  |  |  |  |  |  |
CEO [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of wholly-owned subsidiary shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 51.00% |  |  |  |  |  |  |  |  |  |  |  |  |
TFF [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short term debt borrowing capacity |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 15,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Libor rate description |  |  |  |  |  |  |  |  |  |  |  |  |  | (i) all lending in U.S. dollars is the one-month LIBOR plus six (6%) percent margin; and (ii) for all lending in Euro, the one-month Euribor Rate plus six (6%) percent per annum, commencing June 1, 2018. | (i) all lending in U.S. dollars is the one-month LIBOR plus six (6%) percent margin; and (ii) for all lending in Euro, the one-month Euribor Rate plus six (6%) percent per annum, commencing June 1, 2018. |  |  |  |  |  |  |  |  |  |  |  |
Trade Facility Agreements [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Debt outstanding amount |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 5,866,910 |  |  |  |  |  |  |  |  |
Payment of interest and principal |  |  |  |  |  | $ 1,168,100 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
SkyPharm [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short term debt borrowing capacity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 315,386 |  |  |  |  |  |
Amount withdraw from related party |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,685,038 |  |  |  |  |  |
Accrued interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 349,485 |  |  |  |  |  |
SkyPharm [Member] | MediHelm S.A. [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Amortization of debt discount |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 36,066 |  | 69,269 |  |  |  |  |  |  |  |  |  |  |
Origination fees |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 137,063 |  |  |  |  |  |  |  |  |  |  |  |  |
SkyPharm [Member] | Trade Facility Agreements [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short term debt borrowing capacity | $ 2,464,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Description for the repayment | The total facility will be calculated as 95% of the agreed upon value of Decahedrons receivables. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of credit facility | 12 months |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Credit facility origination fee, percentage | 2.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Monthly credit fee, percentage | 1.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Additional gain on settlement of debt | $ 332,640 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum aggregate amount supplement deed |  |  |  |  |  |  |  |  |  | $ 18,480,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
SkyPharm [Member] | Trade Facility Agreements [Member] | Minimum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short term debt borrowing capacity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 2,464,000 |  |  |  |  |  |  |  |
SkyPharm [Member] | Trade Facility Agreements [Member] | Maximum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short term debt borrowing capacity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 7,392,000 |  |  |  |  |  |  |  |
On April 18, 2018 [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maturity date |  |  |  |  |  |  |  |  |  |  |  |  |  | Dec. 31, 2021 | Dec. 31, 2021 |  |  |  |  |  |  |  |  |  |  |  |
Libor rate description |  |  |  |  |  |  |  |  |  |  |  |  |  | Additionally, the interest rate was amended such that the interest rate for all advances is 4% plus the 3-Month Libor rate. | Additionally, the interest rate was amended such that the interest rate for all advances is 4% plus the 3-Month Libor rate. |  |  |  |  |  |  |  |  |  |  |  |
Gain on debt settlement |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 23,924 |  |  |  |  |  |  |  |  |  |  |  |  |
Loan Facility July 6, 2017 [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fees forgiven related to advance |  |  |  |  |  |  |  |  |  |  |  |  |  | 40,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Loan Agreement 3 [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short term debt borrowing capacity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 5,841 |  |  |  |  |  |  |  |  |  |
Debt outstanding amount |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,841 |  |  |  |  |  |  |  |  |  |  |  |  |
Loan Agreement 2 [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short term debt borrowing capacity |  |  |  |  |  |  | $ 1,752,150 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest rate |  |  |  |  |  |  | 4.70% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maturity date |  |  |  |  |  |  | Mar. 18, 2019 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Debt outstanding amount |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,848,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Accrued interest |  |  |  |  |  |  |  |  |  |  |  |  |  | 23,466 |  |  |  |  |  |  |  |  |  |  |  |  |
Repayment of debt |  |  |  |  |  |  |  |  |  |  |  |  |  | 11,681 |  |  |  |  |  |  |  |  |  |  |  |  |
Loan Facility Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Debt discount |  |  |  |  |  |  |  |  |  |  |  |  |  | 191,034 |  |  |  |  |  |  |  |  |  |  |  |  |
Amortization of debt discount |  |  |  |  |  |  |  |  |  |  |  |  |  | 38,016 |  |  |  |  |  |  |  |  |  |  |  |  |
Unamortized debt discount |  |  |  |  |  |  |  |  |  |  |  |  |  | 23,639 |  |  |  |  |  |  |  |  |  |  |  |  |
Total amortized |  |  |  |  |  |  |  |  |  |  |  |  |  | 114,158 |  |  |  |  |  |  |  |  |  |  |  |  |
Loan Facility Agreement [Member] | SkyPharm [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short term debt borrowing capacity |  |  |  |  | $ 1,292,769 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest rate |  |  |  |  | 10.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Description for the repayment |  |  |  |  | The amounts owed under the Loan Facility shall be repayable upon the earlier of (i) three months following the demand of the lender; or (ii) August 31, 2018. No prepayment is permitted pursuant to the terms of the Loan Facility |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loan Facility Agreement [Member] | Grigorios Siokas [Member] | Synthesis facility agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock shares reserved | shares |  |  |  |  | 10,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Second amendment to loan facility agreement [Member] | SkyPharm [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short term debt borrowing capacity |  |  |  |  |  |  |  |  |  |  | $ 2,664,960 |  |  |  |  | 70,000 |  |  |  | $ 382,327 |  | $ 155,516 | $ 452,471 | $ 250,000 | $ 100,000 | $ 174,000 |
Interest rate |  |  |  |  |  |  |  |  |  |  | 10.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maturity date |  |  |  |  |  |  |  |  |  |  | Aug. 04, 2016 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Description for the repayment |  |  |  |  |  |  |  |  |  |  | The amounts owed under the A&R Loan Facility shall be repayable upon the earlier of (i) seventy five days following the demand of the Lender; or (ii) August 31, 2018. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock shares reserved | shares |  |  |  |  |  |  |  |  |  |  | 1,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Amendment to loan facility agreement [Member] | SkyPharm [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short term debt borrowing capacity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,533,020
Debt outstanding amount |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 240,251
Loan Agreement 1 [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short term debt borrowing capacity |  |  |  |  |  |  |  |  | $ 87,608 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest rate |  |  |  |  |  |  |  |  | 6.50% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maturity date |  |  |  |  |  |  |  |  | Jan. 17, 2019 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loan Agreement 1 [Member] | Grigorios Siokas [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Debt outstanding amount |  |  |  |  |  |  |  |  |  |  |  |  |  | 92,400 |  |  |  |  |  |  |  |  |  |  |  |  |
Accrued interest |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,042 |  |  |  |  |  |  |  |  |  |  |  |  |
Loan agreement [Member] | Panagiotis Drakopoulos [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short term debt borrowing capacity |  |  |  |  |  |  |  |  |  |  |  |  | $ 43,624 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest rate |  |  |  |  |  |  |  |  |  |  |  |  | 6.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maturity date |  |  |  |  |  |  |  |  |  |  |  |  | Nov. 15, 2016 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Debt outstanding amount |  |  |  |  |  |  |  |  |  |  |  |  |  | 27,651 |  | 20,437 |  |  |  |  |  |  |  |  |  |  |
Accrued interest |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,463 |  | $ 2,477 |  |  |  |  |  |  |  |  |  |  |
Bridge Loans [Member] | SkyPharm [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short term debt borrowing capacity |  | $ 34,745 |  | $ 50,000 |  |  |  |  |  |  |  | $ 120,220 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest rate |  | 10.00% |  | 10.00% |  |  |  |  |  |  |  | 10.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maturity date |  | Sep. 30, 2017 |  | Apr. 16, 2017 |  |  |  |  |  |  |  | Apr. 20, 2017 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Amended maturity date |  |  |  | May 16, 2017 |  |  |  |  |  |  |  | May 20, 2017 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Debt outstanding amount |  |  |  | $ 50,000 |  |  |  |  |  |  |  | $ 106,542 |  | 29,745 |  |  |  |  |  |  |  |  |  |  |  |  |
Accrued interest |  |  |  | $ 14,138 |  |  |  |  |  |  |  | 14,138 |  | $ 3,351 |  |  |  |  |  |  |  |  |  |  |  |  |
Gain on debt settlement |  |  |  |  |  |  |  |  |  |  |  | 20,175 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Additional gain on settlement of debt |  |  |  |  |  |  |  |  |  |  |  | 4,781 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loan fixed payoff amount |  |  |  |  |  |  |  |  |  |  |  | $ 106,542 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Decahedron [Member] | SkyPharm [Member] | Trade Facility Agreements [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short term debt borrowing capacity |  |  | $ 3,388,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Description for the repayment |  |  | The total facility will be calculated as 95% of the agreed upon value of Decahedrons receivables |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of credit facility |  |  | 12 months |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Credit facility origination fee, percentage |  |  | 2.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Monthly credit fee, percentage |  |  | 1.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Marathon [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Distribution and equity acquisition agreement, description |  |  |  |  |  |  |  |  |  |  |  |  |  | As consideration for its services, Company received: (a) a 33 1/3% equity interest or 5 million shares in Marathon as partial consideration for the Company’s distribution services; and (b) received cash of CAD $2,000,000, subject to repayment in Common Shares of the Company if it fails to meet certain performance milestones. The Company is entitled to receive an additional CAD $2,750,000 upon the Company’s receipt of gross sales of CAD $6,500,000 and an additional CAD $2,750,000 upon receipt of gross sales of CAD $13,000,000. | As consideration for its services, Company received: (a) a 33 1/3% equity interest or 5 million shares in Marathon as partial consideration for the Company’s distribution services; and (b) received cash of CAD $2,000,000, subject to repayment in Common Shares of the Company if it fails to meet certain performance milestones. The Company is entitled to receive an additional CAD $2,750,000 upon the Company’s receipt of gross sales of CAD $6,500,000 and an additional CAD $2,750,000 upon receipt of gross sales of CAD $13,000,000. |  |  |  |  |  |  |  |  |  |  |  |
Settlement amount |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,554,590 |  |  |  |  |  |  |  |  |  |  |  |  |
Cash received |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 2,000,000 |  |  |  |  |  |  |  |  |  |  |  |
Shares issued for settlement of debt | shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 328,500 | 328,500 |  |  |  |  |  |  |  |  |  |  |  |

X
- References No definition available. + Details
Name: | COSM_AdditionalGainOnSettlementOfDebt
Namespace Prefix: | COSM_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | COSM_AmendedMaturityDate
Namespace Prefix: | COSM_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | COSM_AmountWithdrawFromRelatedParty
Namespace Prefix: | COSM_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- References No definition available. + Details
Name: | COSM_CreditFaciltyOriginationFeePercentage
Namespace Prefix: | COSM_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | COSM_DistributionAndEquityAgreementDescription
Namespace Prefix: | COSM_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | COSM_GainOnDebtSettlement
Namespace Prefix: | COSM_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | COSM_LiborRateDescription
Namespace Prefix: | COSM_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | COSM_LoanFacilityForgave
Namespace Prefix: | COSM_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | COSM_LoanFixedPayoffAmount
Namespace Prefix: | COSM_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- References No definition available. + Details
Name: | COSM_MaximumAggregateAmountSupplementDeed
Namespace Prefix: | COSM_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | COSM_MonthlyCreditFeePercentage
Namespace Prefix: | COSM_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | COSM_PercentageOfWhollyownedSubsidiaryShares
Namespace Prefix: | COSM_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_AccruedLiabilitiesCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28541-108399 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.8) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_AmortizationOfDebtDiscountPremium
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The net increase(decrease) in interest income during the period representing the allocation of deferred loan origination fees less deferred loan origination costs using the effective interest method over the term of the debt arrangement to which they pertain taking into account the effect of prepayments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.1) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 20 -Section 30 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6378273&loc=d3e8446-111530 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 20 -Section 25 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6962437&loc=d3e7402-111529 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 20 -Section 35 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=82894254&loc=d3e8622-111531 + Details
Name: | us-gaap_AmortizationOfDeferredLoanOriginationFeesNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.2) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_AvailableForSaleSecuritiesAmortizedCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount paid or received to resolve the preacquisition contingency. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 340 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 2.A.6) -URI http://asc.fasb.org/extlink&oid=27011391&loc=d3e105049-122735 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3179-108585 + Details
Name: | us-gaap_CashAcquiredFromAcquisition
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Aggregate number of common shares reserved for future issuance. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockCapitalSharesReservedForFutureIssuance
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586 + Details
Name: | us-gaap_DebtConversionConvertedInstrumentSharesIssued1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of the required periodic payments applied to interest. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_DebtInstrumentPeriodicPaymentInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | us-gaap_DebtInstrumentTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, after accumulated amortization, of debt discount. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28541-108399 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 55 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400 + Details
Name: | us-gaap_DebtInstrumentUnamortizedDiscount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28541-108399 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 55 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400 + Details
Name: | us-gaap_DebtInstrumentUnamortizedDiscountCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(16)) -URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(16)) -URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878 + Details
Name: | us-gaap_LineOfCredit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Description of the terms of a credit facility arrangement. Terms typically include interest rate, collateral required, guarantees required, repayment requirements, and restrictions on use of assets and activities of the entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_LineOfCreditFacilityDescription
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Date the credit facility terminates, in CCYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_LineOfCreditFacilityExpirationDate1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition The effective interest rate during the reporting period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_LineOfCreditFacilityInterestRateDuringPeriod
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations. + References No definition available. + Details
Name: | us-gaap_RepaymentsOfDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_TitleOfIndividualAxis=us-gaap_ChiefExecutiveOfficerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TitleOfIndividualAxis=COSM_TFFMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DeferredRevenueArrangementTypeAxis=COSM_TradeFacilityAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_SkyPharmMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=COSM_MediHelmSAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CreationDateAxis=COSM_OnAprilEighteen2018Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CreationDateAxis=COSM_LoanFacilityJulySixTwoThousandSeventeenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=COSM_LoanAgreementThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=COSM_LoanAgreementTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=COSM_LoanFacilityAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_GrigoriosSiokasMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=COSM_SynthesisFacilityAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=COSM_SecondAmendmentToLoanFacilityAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=COSM_AmendmentToLoanFacilityAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=COSM_LoanAgreementOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=COSM_LoanAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_PanagiotisDrakopoulosMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=COSM_BridgeLoansMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=COSM_DecahedronMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=COSM_MarathonMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |